After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

You may have done your research and settled on Wegovy for weight management or cardiovascular health. Now what? Telemedicine options might be your ticket to fulfill the prescription, deliver it ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its direct-to-patient online pharmacy, as competition in the highly ...

The drugmaker has named its new program NovoCare® Pharmacy, which will sell all dose strengths of Wegovy at $499 per month. According to the company, about 90 percent most patients pay a monthly ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to ...

Who is eligible for both Medicare and Medicaid in California? Beneficiaries with dual eligibility Wegovy has gained attention as a powerful weight loss medication, especially for those struggling ...

Novo Nordisk is introducing a direct-to-patient delivery option for its flagship weight loss drug Wegovy (semaglutide), slashing the price of the drug for cash-paying patients without insurance ...

The specialty pharmacy business may be the most attractive part of Walgreens as rumors swirl the company will be taken over ...